Skip to content

A study to compare cisatracurium and atracurium during general anesthesia.

A comparative study of onset, duration and intubating conditions of cisatracurium and atracurium during general anesthesia. - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064761
Enrollment
90
Registered
2024-03-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K800- Calculus of gallbladder with acutecholecystitis Health Condition 2: N200- Calculus of kidney Health Condition 3: H65-H75- Diseases of middle ear and mastoid Health Condition 4: K315- Obstruction of duodenum Health Condition 5: N630- Unspecified lump in unspecified breast

Interventions

Intervention1: Injection Atracurium: Injection Atracurium 0.5mg/kg (2xED95) loading dose to first maintenance dose in general anesthesia surgeries. Control Intervention1: Injection Cisatracurium: Inj

Sponsors

Pacific Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient willing to give consent. Age between 18 to 65 years of both sexes Patients belonging to ASA Grade - I and II Mallampati Classification – I and II Elective Surgeries Weight 50 – 80kg

Exclusion criteria

Exclusion criteria: Patients who have refused consent. Patients with Neuromuscular disease Known or anticipated difficult airway Patient receiving drugs known to interact with neuromuscular blocking agents Pregnant and lactating women Patients with cardiovascular, hepatic and renal disorders Patients with known drug allergy to any of the study drugs

Design outcomes

Primary

MeasureTime frame
Through this study we will be able to know whether Cisatracurium or Atracurium is a better non-depolarizing muscle relaxant in regards to onset, duration and intubating conditions during General Anesthesia.Timepoint: 24 months

Secondary

MeasureTime frame
Same as aboveTimepoint: 24 months

Countries

India

Contacts

Public ContactJosiah Peter Andrews

Pacific Medical College and Hospital

sameergoy@yahoo.com8890802830

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026